33 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27717652	275	Synthesis and evaluation of the structural elements in alkylated tetrahydroisoquinolines for binding to CNS receptors.	Florida A&M University
27312422	219	Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands.	Florida A&M University
25070422	126	Further evaluation of the tropane analogs of haloperidol.	Florida A&M University
24800940	146	Identification of a new selective dopamine D4 receptor ligand.	Florida A&M University
11454468	35	Discovery and SAR of org 24598-a selective glycine uptake inhibitor.	Organon Research and Development Group
22520153	135	Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants.	Florida A&M University
19744859	90	Dibenzazecine scaffold rebuilding--is the flexibility always essential for high dopamine receptor affinities?	Friedrich-Schiller-Universit£T Jena
15239663	60	Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction.	Abbott Laboratories
22336245	72	Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol.	Florida A&M University
22245230	128	Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents.	Florida A&M University
22039961	21	Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding.	Forschungszentrum J£Lich
20873719	12	Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.	Universita` Degli Studi Di Bari A Moro
20812727	157	Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.	National Institute of Mental Health
17149874	110	Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-[2,4'-bipyridine]-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction.	Abbott Laboratories
16250661	13	11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.	University of Milano/Bicocca
15857123	51	Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.	University of Michigan
15341484	159	Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.	Merck
11378358	254	Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.	Columbia University College of Physicians and Surgeons
8691438	48	(S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.	Pharmacia & Upjohn
26684482	20	Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.	North-West University